tradingkey.logo

Bone Biologics Corp

BBLG
查看詳細走勢圖
1.400USD
+0.050+3.70%
收盤 02/06, 16:00美東報價延遲15分鐘
2.51M總市值
虧損本益比TTM

Bone Biologics Corp

1.400
+0.050+3.70%
盤中分時
1分
30分
1小時
日k
週k
月k
日k

今天

+3.70%

5天

-14.63%

1月

-10.83%

6月

-44.88%

今年開始到現在

-3.45%

1年

-79.35%

查看詳細走勢圖

TradingKey Bone Biologics Corp股票評分

單位: USD 更新時間: 2026-02-06

操作建議

Bone Biologics Corp當前公司基本面數據相對非常健康,最新ESG揭露屬於行業領先水平。增長潛力很大。當前估值合理,在生物技術與醫療研究行業排名236/392位。機構持股佔比非常高,近一月多位分析師給出公司評級為。最高目標價為22.25。中期看,股價處於下降通道。近一個月,市場表現較差,但基本面評分較高。目前股價在壓力位和支撐位之間,可以做區間波段操作。

Bone Biologics Corp評分

相關信息

行業排名
236 / 392
全市場排名
517 / 4521
所屬行業
生物技術與醫療研究

壓力支撐

由於公司未披露,未能獲取相關數據

多維評測

本期評分
上期評分

公司輿情

過去24小時
熱度

過冷
過熱
中性

Bone Biologics Corp亮點

亮點風險
Bone Biologics Corporation is a clinical-stage developer of orthobiologic products for spine fusion markets. The Company is focused on bone regeneration in lumbar spinal fusion using neural epidermal growth factor-like 1 protein (NELL-1) in combination with demineralized bone matrix (DBM), a demineralized bone matrix from the Musculoskeletal Transplant Foundation (MTF) Biologics. The combination NELL-1/DBM medical device is an osteopromotive recombinant protein that provides target specific control over bone regeneration. NELL-1 in combination with DBM. NELL-1, a proprietary skeletal-specific growth factor that is a bone void filler. NELL-1 provides regulation over skeletal tissue formation and stem cell differentiation during bone regeneration. The DBM Demineralized Bone Putty provided as part of the convenience kit with NELL-1/DBM is a Class II device. DBM Putty is a matrix composed of processed human cortical bone.
利潤高增長
公司淨利潤處於行業前列,最新年度總收入0.00美元
估值低估
公司最新PE估值-0.59,處於3年歷史低位

分析師目標

基於 0 分析師
--
評級
22.250
目標均價
+1344.81%
漲幅空間
數據免責聲明:分析師評級與目標價由LSEG提供,僅供參考,不應當作投資建議

Bone Biologics Corp新聞

即將為您帶來更多新聞,敬請期待。 。 。

財務指標

每股收益

由於公司未披露,未能獲取相關數據

營業總收入

由於公司未披露,未能獲取相關數據

Bone Biologics Corp簡介

Bone Biologics Corporation is a clinical-stage developer of orthobiologic products for spine fusion markets. The Company is focused on bone regeneration in lumbar spinal fusion using neural epidermal growth factor-like 1 protein (NELL-1) in combination with demineralized bone matrix (DBM), a demineralized bone matrix from the Musculoskeletal Transplant Foundation (MTF) Biologics. The combination NELL-1/DBM medical device is an osteopromotive recombinant protein that provides target specific control over bone regeneration. NELL-1 in combination with DBM. NELL-1, a proprietary skeletal-specific growth factor that is a bone void filler. NELL-1 provides regulation over skeletal tissue formation and stem cell differentiation during bone regeneration. The DBM Demineralized Bone Putty provided as part of the convenience kit with NELL-1/DBM is a Class II device. DBM Putty is a matrix composed of processed human cortical bone.
公司代碼BBLG
公司Bone Biologics Corp
CEOFrelick (Jeffrey)
網址https://www.bonebiologics.com/
KeyAI